Financial Year |
March 31 2023 |
Monetary Funds |
11,642,143,988.78 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
893,254,279.67 |
Advances to Suppliers |
8,618,178,782.40 |
Other Receivables |
35,592,420,823.13 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
11,397,071.78 |
Inventories |
179,018,932,670.29 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
7,781,866,092.94 |
Total Current Assets |
244,456,680,978.84 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
25,878,832,471.57 |
Investment Properties |
13,636,140,033.37 |
Fixed Assetes |
2,563,004,719.40 |
Under-construction Projects |
15,924,560.78 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
190,569,174.22 |
R&D expenses |
-- |
Goodwill |
2,639,186.68 |
Long-Term Deferred and Prepaid Expenses |
51,023,355.43 |
Deferred Income Tax Assets |
5,102,227,972.36 |
Other Non-Current Assets |
5,000,000.00 |
Sub-Total of Non-Current Assets |
48,607,023,434.75 |
Total Assets |
293,063,704,413.59 |
Short-Term Loans |
7,220,415,432.08 |
Trading Financial liabilities |
2,041,711,186.29 |
Notes Payable |
51,870,850.69 |
Accounts Payable |
29,668,472,382.23 |
Accounts Received In Advance |
55,229,167.39 |
Employee Compensation Payable |
1,024,023,226.34 |
Taxes Payable |
4,715,394,589.02 |
Interest Payable |
2,390,012,985.00 |
Dividend Payable |
87,229,913.34 |
Other payables |
42,648,014,246.25 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
32,052,417,678.20 |
Other Current Liabilities |
5,009,144,416.73 |
Sub-Total of Current Liabilities |
221,891,709,424.80 |
Long-term Loans |
18,723,387,855.69 |
Bonds Payable |
11,188,984,317.45 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
788,852,493.76 |
Deferred Income Tax Liabilities |
2,048,760,988.82 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
33,046,994,799.73 |
Total Liabilities |
254,938,704,224.53 |
Paid-In Capital(Or Share Stock) |
5,339,715,816.00 |
Capital Surplus |
6,903,384,166.49 |
Surplus Reserve |
2,493,398,991.79 |
LESS:Treasury Stock |
188,262,821.63 |
Undistributed Profits |
-3,980,198,267.96 |
Minority Stockholder's Interest |
25,979,788,704.06 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,145,211,485.00 |
Owner's Equity(Stockholder's Equity) |
38,125,000,189.06 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
293,063,704,413.59 |